In breast cancer, Galectin-3 (Gal3) acts as a multifunctional protein that helps the tumor survive, travel, and hide. It is found both inside the cell (cytoplasm/nucleus) and outside in the tumor microenvironment.

1. The "Velcro" of Metastasis (Extracellular)

For a breast tumor to spread to other organs (like the lungs or bones), cancer cells must leave the primary tumor and survive the "harsh" environment of the bloodstream. Gal3 is famously known as the "molecular velcro" of the bloodstream.

• The MUC1 Interaction: On the surface of cancer cells, Gal3 binds to a large protein called MUC1. This interaction exposes adhesion molecules that allow cancer cells to "dock" onto the lining of blood vessels.

• Seeding the Soil: This helps circulating tumor cells (CTCs) stop and invade distant organs, particularly the lungs and bones, facilitating the spread of the disease.

• Migration: It acts like a "glue," allowing cells to grip the extracellular matrix (the scaffolding between cells) to move into new tissues.

2. The "Anti-Death Shield" Against Chemotherapy (Intracellular)

One of the biggest challenges in treating breast cancer is apoptosis resistance—when cancer cells refuse to die even when treated with chemotherapy. Inside the breast cancer cell, Gal3 acts as a guardian of the mitochondria.

• The NWGR Motif: Inside the cell, Gal-3 contains a specific sequence of amino acids (NWGR) that is almost identical to the Bcl-2 protein (a famous "pro-survival" protein). This motif allows Gal-3 to block the signals that tell a cell to self-destruct. Research shows that high levels of Gal-3 can make Triple-Negative Breast Cancer (TNBC) resistant to drugs like arsenic trioxide.

• Anti-Apoptotic Power: It prevents "programmed cell death" (apoptosis). When chemotherapy drugs try to trigger the cell to die, Gal3 stabilizes the cell’s internal structures, allowing the cancer to survive and become drug-resistant.

3. The "Immune Cloak"

Gal3 is secreted into the space around the tumor to deactivate the body’s natural defenses.

• LAG-3 Activation: When Gal-3 binds to LAG-3, an inhibitory "checkpoint" receptor, it sends a strong "stop" signal to the T cell.

• T-celll Functional Paralysis: This binding is necessary for Gal-3 to suppress T cell effector function. Without Gal-3, T cells in the tumor microenvironment are significantly more active and inflammatory against the tumor.

• Macrophage Subversion: Gal-3 "re-programs" macrophages (the body's cleanup cells). Instead of eating cancer cells, these macrophages become "pro-tumor," actually helping the cancer grow and build new blood vessels (angiogenesis).